Akoya Biosciences, Inc.

AKYA · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$11,779$83,125$74,229$113,079
Short-Term Investments$23,261$0$6,989$0
Receivables$13,779$16,994$9,729$9,444
Inventory$24,321$17,877$14,486$9,014
Other Curr. Assets$3,592$3,794$6,764$9,277
Total Curr. Assets$76,732$121,790$112,197$140,814
Property Plant & Equip (Net)$12,983$20,656$22,449$7,487
Goodwill$18,262$18,262$18,262$18,262
Intangibles$14,559$17,412$20,048$21,150
Long-Term Investments$0$699$303$302
Tax Assets$0$0-$303-$302
Other NC Assets$2,469$1,550$3,075$3,194
Total NC Assets$48,273$58,579$63,834$50,093
Other Assets$0$0$0$0
Total Assets$125,005$180,369$176,031$190,907
Liabilities
Payables$8,759$11,776$10,628$9,435
Short-Term Debt$6,566$3,448$3,629$544
Tax Payable$0$0$0$0
Deferred Revenue$6,554$6,688$6,279$4,484
Other Curr. Liab.$7,565$13,433$16,519$13,219
Total Curr. Liab.$29,444$35,345$37,055$27,682
LT Debt$80,863$82,258$72,155$32,668
Deferred Rev, NC$3,063$3,193$2,114$1,330
Deferred Tax Liab, NC$129$38$87$26
Other NC Liab.$3,911$5,765$6,039$7,850
Total NC Liab.$87,966$91,254$80,395$41,874
Other Liabilities$0$0$0$0
Cap. Leases$7,964$10,452$12,507$469
Total Liabilities$117,410$126,599$117,450$69,556
Equity
Pref Stock$0$0$0$190,907
Common Stock$2$2$2$2
Retained Earnings-$285,436-$230,071-$166,748-$96,107
AOCI$7$0-$6$0
Other Equity$293,022$283,839$225,333$26,549
Total Equity$7,595$53,770$58,581$121,351
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$125,005$180,369$176,031$190,907
Net Debt$75,650$2,581$1,555-$79,867
Akoya Biosciences, Inc. (AKYA) Financial Statements & Key Stats | AlphaPilot